1 unknown. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
Follow Stevens-Johnson Syndrome: new trials by email Literature Review of Stevens-Johnson Syndrome trials Research Report on Stevens-Johnson Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis Abrocitinib, Tofacitinib - Toxic Epidermal Necrolysis | Early Phase 1 | Unknown | Peng Zhang | 30 | 2023-07-05 | 2023-11-28 |
Chemically-Induced Disorders (1) · Dermatitis (1) · Drug Eruptions (1) · Drug Hypersensitivity (1) · Drug-Related Side Effects and Adverse Reactions (1) · Erythema (1) · Erythema Multiforme (1) · Hypersensitivity (1) · Hypersensitivity, Delayed (1) · Immune System Diseases (1) · Mouth Diseases (1) · Skin Diseases (1) · Skin Diseases, Vesiculobullous (1) · Skin and Connective Tissue Diseases (1) · Stomatitis (1)
Methylprednisolone Hemisuccinate (1) · abrocitinib (1) · tofacitinib (1)
Peng Zhang (1)
China (1)